Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Marie Deen"'
Autor:
Casper Emil Christensen, Samaira Younis, Marie Deen, Sabrina Khan, Hashmat Ghanizada, Messoud Ashina
Publikováno v:
The Journal of Headache and Pain, Vol 19, Iss 1, Pp 1-9 (2018)
Abstract Background Migraine prevention with erenumab and migraine induction by calcitonin gene-related peptide (CGRP) both carry notable individual variance. We wanted to explore a possible association between individual efficacy of anti-CGRP treatm
Externí odkaz:
https://doaj.org/article/bd01f735b7034f2c8aa24c34f8a40a94
Autor:
Eloisa Rubio-Beltrán, Edvige Correnti, Marie Deen, Katharina Kamm, Tim Kelderman, Laura Papetti, Simone Vigneri, Antoinette MaassenVanDenBrink, Lars Edvinsson, On behalf of the European Headache Federation School of Advanced Studies (EHF-SAS)
Publikováno v:
The Journal of Headache and Pain, Vol 19, Iss 1, Pp 1-11 (2018)
Abstract Pituitary adenylate cyclase activating polypeptide-38 (PACAP38) is a widely distributed neuropeptide involved in neuroprotection, neurodevelopment, nociception and inflammation. Moreover, PACAP38 is a potent inducer of migraine-like attacks,
Externí odkaz:
https://doaj.org/article/cc24ea64fb8e43228d9f9669e2e4f03a
Autor:
Marie Deen, Hanne D. Hansen, Anders Hougaard, Martin Nørgaard, Hans Eiberg, Szabolcs Lehel, Messoud Ashina, Gitte M. Knudsen
Publikováno v:
NeuroImage: Clinical, Vol 18, Iss , Pp 97-102 (2018)
Migraine has been hypothesized to be a syndrome of chronic low serotonin (5-HT) levels, but investigations of brain 5-HT levels have given equivocal results. Here, we used positron emission tomography (PET) imaging of the 5-HT4 receptor as a proxy fo
Externí odkaz:
https://doaj.org/article/2495f415ceb24ef8a34ca542d043d1d9
Autor:
Marie Deen, Edvige Correnti, Katharina Kamm, Tim Kelderman, Laura Papetti, Eloisa Rubio-Beltrán, Simone Vigneri, Lars Edvinsson, Antoinette Maassen Van Den Brink, On behalf of the European Headache Federation School of Advanced Studies (EHF-SAS)
Publikováno v:
The Journal of Headache and Pain, Vol 18, Iss 1, Pp 1-9 (2017)
Abstract Migraine is the most prevalent neurological disorder worldwide and it has immense socioeconomic impact. Currently, preventative treatment options for migraine include drugs developed for diseases other than migraine such as hypertension, dep
Externí odkaz:
https://doaj.org/article/d2ba45670bee4a83b7dd02bf83f5592e
Autor:
Schoenen, Jean, Snoer, Agneta Henriette, Brandt, Roemer B, Fronczek, Rolf, Wei, Diana Y, Chung, Chin-Sang, Diener, Hans Christoph, Dodick, David W, Fontaine, Denys, Goadsby, Peter J, Matharu, Manjit Singh, May, Arne, McGinley, James S, Tepper, Stewart J, Jensen, Rigmor Højland, Ferrari, Michel D, Terwindt, Gisela, Tassorelli, Cristina, Ashina, Messoud, Leroux, Elizabeth, Lipton, Richard B, Pozo-Rosich, Patricia, Wang, Shuu-Jiun, Christensen, Marie Deen, Martini, Daniela, van den Hoek, Thomas
Publikováno v:
Cephalalgia, 42(14), 1450-1466. SAGE PUBLICATIONS LTD
In 1995, a committee of the International Headache Society developed and published the first edition of the Guidelines for Controlled Trials of Drugs in Cluster Headache. These have not been revised. With the emergence of new medications, neuromodula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07e71f614e66df0f609da6307c637cd7
https://hdl.handle.net/1887/3505076
https://hdl.handle.net/1887/3505076
Autor:
Hans-Christoph Diener, Gisela M. Terwindt, Messoud Ashina, Rigmor Jensen, Patricia Pozo-Rosich, Marie Deen, Stephen D. Silberstein, David W. Dodick, Hsiangkuo Yuan, Daniele Martinelli, Cristina Tassorelli, Thomas C van den Hoek, Delphine Magis, Peter J. Goadsby
Publikováno v:
Cephalalgia, 41(11-12), 1135-1151. SAGE PUBLICATIONS LTD
Background Although the European Medicines Agency and the US Food and Drug Administration have cleared several devices that use neuromodulation to provide clinical benefits in the acute or preventive treatment of migraine, the Clinical Trials Committ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b1af6c934bcabd412f50eb56411ab62
https://doi.org/10.1177/03331024211010413
https://doi.org/10.1177/03331024211010413
Autor:
Sabrina Khan, Samaira Younis, Hashmat Ghanizada, Marie Deen, Casper Emil Christensen, Messoud Ashina
Publikováno v:
The Journal of Headache and Pain, Vol 19, Iss 1, Pp 1-9 (2018)
The Journal of Headache and Pain
Christensen, C E, Younis, S, Deen, M, Khan, S, Ghanizada, H & Ashina, M 2018, ' Migraine induction with calcitonin gene-related peptide in patients from erenumab trials ', The Journal of Headache and Pain, vol. 19, 105 . https://doi.org/10.1186/s10194-018-0927-2
The Journal of Headache and Pain
Christensen, C E, Younis, S, Deen, M, Khan, S, Ghanizada, H & Ashina, M 2018, ' Migraine induction with calcitonin gene-related peptide in patients from erenumab trials ', The Journal of Headache and Pain, vol. 19, 105 . https://doi.org/10.1186/s10194-018-0927-2
BACKGROUND: Migraine prevention with erenumab and migraine induction by calcitonin gene-related peptide (CGRP) both carry notable individual variance. We wanted to explore a possible association between individual efficacy of anti-CGRP treatment and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e314e3c021ad0c3d9fa45cc0e683da4
http://link.springer.com/article/10.1186/s10194-018-0927-2
http://link.springer.com/article/10.1186/s10194-018-0927-2
Autor:
Anders Hougaard, Gitte M. Knudsen, Szabolcs Lehel, Hans Eiberg, Claus Svarer, Hanne D. Hansen, Messoud Ashina, Marie Deen
Publikováno v:
Cephalalgia. 39:526-532
IntroductionSerotonin (5-HT) plays a role in migraine pathophysiology, but whether brain 5-HT is involved in the conversion from episodic to chronic migraine is unknown. Here, we investigated brain 5-HT levels, as indexed by 5-HT4receptor binding, in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b5779fb62ef37403bf1dbe702c5eb9f
https://doi.org/10.1177/0333102418793642
https://doi.org/10.1177/0333102418793642
Autor:
Marie Deen, Claus Svarer, Gitte M. Knudsen, Sune H. Keller, Anders Hougaard, Martin Nørgaard, Sofi da Cunha-Bang, Messoud Ashina, Hanne D. Hansen, Carsten Thomsen
Publikováno v:
Cephalalgia. 38:519-527
Background The pathophysiology of migraine may involve dysfunction of serotonergic signaling. In particular, the 5-HT1B receptor is considered a key player due to the efficacy of 5-HT1B receptor agonists for treatment of migraine attacks. Aim To exam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6dbdc222d95a181111aae2ac66acd46
https://doi.org/10.1177/0333102417698708
https://doi.org/10.1177/0333102417698708
Autor:
Simona Denise Frederiksen, Lars Edvinsson, Agneta Snoer, Marie Deen, Maria Bekker-Nielsen Dunbar
Publikováno v:
HeadacheReferences. 60(6)
Objective: The aim of this systematic review and meta-analysis (SR-MA) was to identify signaling molecule profiles and blood-derived biomarkers in migraine and cluster headache (CH) patients. Background: Currently no migraine and CH valid biomarkers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80434e10b0639d6a499bdb39d7f0e796
https://pubmed.ncbi.nlm.nih.gov/32293721
https://pubmed.ncbi.nlm.nih.gov/32293721